Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06547801 · ClinicalTrials.gov registry record · NA
Effects of Human Milk Oligosaccharide Ingestion on Weight Loss and Markers of Health
A NA study of Weight Loss, sponsored by Advanced Protein Technologies Corporation.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
- 1
- Study location
NCT06547801 is a NA study of Weight Loss that has completed, run by Advanced Protein Technologies Corporation. The registered enrollment target is 60 participants, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT06547801, a NA study of Weight Loss, has completed, sponsored by Advanced Protein Technologies Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
- 1
- Study location
Study Summary
A randomized, double-blind, placebo-controlled, parallel arm study of 2'-fucosyllactose (2'-FL) was conducted in healthy males and females between the ages of 18 and 65 at the time of consent. 2'-FL is one of the most prominent HMOs in human milk. Preclinical studies indicate that 2'-FL feeding is prebiotic, anti-inflammatory, anti-thrombotic, and may reduce skeletal muscle atrophy during energy restriction. The investigators hypothesize that supplementation of 2'-FL affects the preservation of muscle mass, strength, and markers of health during exercise and a hypo-energetic weight loss program. To test this hypothesis, the investigators will compare 3 g/day of 2'-FL with 3 g/day of maltodextrin placebo as a daily supplement.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Maltodextrin
- DIETARY_SUPPLEMENT 2'-Fucosyllactose
Study Locations (1)
Texas
- Exercise & Sport Nutrition Lab, Department of Kinesiology and Sport Management, Texas A&M University, College Station - College Station
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2023-05-04 |
| Est. Completion | 2024-02-22 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06547801
The ClinicalTrials.gov registry entry for NCT06547801 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,501-participant average among 116 other Weight Loss trials with a reported enrollment target (96% lower). The listed sponsor is Advanced Protein Technologies Corporation, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Weight Loss appearing as the primary indexed condition, and to 2 interventions - of which Maltodextrin is the first listed.
NCT06547801 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT06547801 about?
NCT06547801 is a clinical study titled "Effects of Human Milk Oligosaccharide Ingestion on Weight Loss and Markers of Health". A randomized, double-blind, placebo-controlled, parallel arm study of 2'-fucosyllactose (2'-FL) was conducted in healthy males and females between the ages of 18 and 65 at the time of consent. 2'-FL is one of the most prominent HMOs in human milk. Preclinical studies indicate that 2'-FL feeding is p...
What is the current status of trial NCT06547801?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2023-05-04. Estimated completion is 2024-02-22.
What conditions does trial NCT06547801 study?
This clinical trial studies the following conditions: Weight Loss.
What interventions are being tested in trial NCT06547801?
The interventions under investigation include: Maltodextrin (DIETARY_SUPPLEMENT), 2'-Fucosyllactose (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT06547801?
This trial is sponsored by Advanced Protein Technologies Corporation, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06547801 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Weight Loss
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Metabolic Adaptations to Weight Loss With and Without Exercise
RECRUITING · NA
-
Metabolic Health, Bones and Nuts During Weight Loss in Adults
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Exercise Effects on Adipose Tissue Structure and Function
RECRUITING · NA
-
Circadian Time Restricted Eating
RECRUITING · NA
-
Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.